Form 6-K uniQure N.V. For: Aug 27

Go back to Form 6-K uniQure N.V. For: Aug 27

Chardan Capital Trims PT on uniQure (QURE) to $35; Notes Uncertainty of Glybera in the U.S.

August 27, 2015 12:02 PM EDT

Chardan Capital trims its price target on uniQure N.V. (Nasdaq: QURE) from $40 to $35 and maintains a Buy rating following Q2 results and update issued earlier.

Analyst Gbola Amusa noted that the lowered price target stems from (1) uncertainty for Glybera... More